Telehealth Could Mitigate Disease Progression Compared to Standard of Care in COPD - a Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04485832

Enrollment

168

Registered

2020-07-24

Start date

2016-04-05

Completion date

2019-12-01

Last updated

2020-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The objective of this randomised controlled trial is to test, whether telehealthcare can improve HRQOL and reduce emergency admissions and hospitalisations due to AECOPD. Different outcome parameters as described in the endpoints section will be analysed.

Interventions

DEVICETelehealth care

Patients in the intervention group daily answer 6 questions, which are focused on the recognition of AECOPD, using the electronic healthcare platform Evita by Swisscom, which has been and continuously is developed by the study team and Swisscom. The study team daily analyses all patients online and reacts according to a pre-specified action plan.

DIAGNOSTIC_TESTWeekly CAT measurement

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* COPD GOLD B-D and age ≥ 40 years

Exclusion criteria

* Inability to provide informed consent or to follow trial procedures

Design outcomes

Primary

Measure	Time frame
Change of COPD assessment test (CAT) at 6 months (slope of the linear regression trend)	1 year after inclusion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026